The difference between a good injection site and the optimal one might not show up in a single dose, but over weeks and months of consistent use, small advantages compound into meaningful outcomes
GLP-1 drugs have rapidly revolutionized the treatment of Type 2 diabetes and obesity, with promising future applications for other medical problems, including addiction, on the horizon
Novak V, Mantzoros CS, Novak P, McGlinchey R, Dai W, Lioutas V, Buss S, Fortier CB et al (2022) MemAID: memory advancement with intranasal insulin vs
Because those younger than 65 years of age would not be captured by the ODB database, another cohort was created
It can only become pathogenic when exaggerated, as in insulin-resistant obesity [15]
Wolffe, A